Hakkı Yılmaz

590 citations
24 papers · 405 indexed · h-index 11

Hakkı Yılmaz

21 papers receiving 394 citations

Peers

Hakkı Yılmaz
Comparison fields: 5 of 70
  • Epidemiology 86
  • Nephrology 82
  • Obstetrics and Gynecology 78
  • Immunology 77
  • Oncology 73
Replace Ivo Lukitsch with:
Ivo Lukitsch United States
Berta Soldevila Spain
Osman İnan Türkiye
Umut Selda Bayrakçı Türkiye
Mehmet Ali Kösekli Türkiye
Meryl C. Nath United States
Renata Świątkowska−Stodulska Poland
P. Chudoba Poland
Marios Papasotiriou Greece
Francine Brambate Carvalhinho Lemos Brazil
Hakkı Yılmaz relative to Ivo Lukitsch United States Ivo Lukitsch's profile →
Citations per field
00.5×2.8×
Ivo Lukitsch · 1×
Citations per year

Countries citing papers authored by Hakkı Yılmaz

Since Specialization
Citations

This map shows the geographic impact of Hakkı Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakkı Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakkı Yılmaz more than expected).

Fields of papers citing papers by Hakkı Yılmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakkı Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakkı Yılmaz. The network helps show where Hakkı Yılmaz may publish in the future.

Co-authorship network of co-authors of Hakkı Yılmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Hakkı Yılmaz. A scholar is included among the top collaborators of Hakkı Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakkı Yılmaz. Hakkı Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 10
3 8
4 1
5 4
6 7
7 35
8 18
9 66
10 60
11 11
12 6
13
Correlation between Cystatin C and Creatinine Clearance among Primary Glomerulonephritis Patients with Stage 1-4 Chronic Renal Failure
0
14 3
15 0
16 11
17 26
18 38
19 3
20 0

About Hakkı Yılmaz

Hakkı Yılmaz is a scholar working on Nephrology, Obstetrics and Gynecology and Endocrinology, Diabetes and Metabolism, having authored 24 papers that have together received 405 indexed citations. Recurring topics across this work include Pregnancy and preeclampsia studies (3 papers), Biomarkers in Disease Mechanisms (2 papers) and Vitamin D Research Studies (2 papers). The work is most often cited by research in Nephrology (82 citations), Obstetrics and Gynecology (78 citations) and Immunology (77 citations). Hakkı Yılmaz has collaborated with scholars based in Türkiye, Poland and United States. Frequent co-authors include Ali Akçay, Osman İnan, Muzaffer Çakmak, Tahir Darçın, Nüket Bavbek, Mehmet Namuslu, Mustafa Şahi̇n, Tuncay Delibaşı, Beyhan Eryonucu and Hüseyin Çelik. Their work appears in journals such as Biological Trace Element Research, Diabetes & Metabolic Syndrome Clinical Research & Reviews and Experimental and Clinical Endocrinology & Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026